MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 227 filers reported holding MYRIAD GENETICS INC in Q3 2016. The put-call ratio across all filers is 1.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,535,000 | -70.6% | 44,726 | -69.0% | 0.10% | +472.2% |
| Q3 2017 | $5,225,000 | -35.7% | 144,412 | -54.1% | 0.02% | -33.3% |
| Q2 2017 | $8,131,000 | +1927.7% | 314,662 | +1405.6% | 0.03% | +2600.0% |
| Q1 2017 | $401,000 | +15.2% | 20,899 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $348,000 | -15.5% | 20,899 | +4.3% | 0.00% | 0.0% |
| Q3 2016 | $412,000 | -29.5% | 20,030 | +4.9% | 0.00% | -50.0% |
| Q2 2016 | $584,000 | – | 19,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 6,459,139 | $278,776,000 | 5.53% |
| Tieton Capital Management, LLC | 119,290 | $5,149,000 | 4.04% |
| RPg Family Wealth Advisory, LLC | 97,202 | $4,195,238,000 | 3.85% |
| RK Capital | 384,900 | $16,612,000 | 2.90% |
| Contrarius Investment Management Ltd | 652,288 | $28,153,000 | 2.65% |
| S&T BANK/PA | 331,885 | $14,324,000 | 2.22% |
| Euclidean Technologies Management, LLC | 40,917 | $1,766,000 | 1.90% |
| AIMZ Investment Advisors, LLC | 45,635 | $1,970,000 | 1.80% |
| Taylor Frigon Capital Management LLC | 34,783 | $1,486,000 | 1.67% |
| KILLEN GROUP INC | 366,305 | $15,810,000 | 1.63% |